NK

Nagender Kumar

Active Director Director DIN 07515867
DIN 07515867 First appointment Jul 2016 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Nagender Kumar

Data last updated:

Nagender Kumar is a Director at Tervist Pharmaceuticals Private Limited (since 2016). The company operates in Business Services. Tervist Pharmaceuticals Private Limited reported revenue of ₹29,800 (FY 2021).

DIN 07515867
Primary Designation Director
Industry Business Services
First Appointment 01 Jul 2016
Oldest Company Age 10 yrs
Largest company Tervist Pharmaceuticals Private Limited · ₹29,800 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20162016₹29,800 (FY 2021)Active

Board colleagues of Nagender Kumar

Directorship timeline

Open interactive timeline →
Tervist Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nagender Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagender Kumar

Nagender Kumar currently holds 1 directorship: Tervist Pharmaceuticals Private Limited (Director, since 01 Jul 2016, revenue ₹29,800 (FY 2021)).

Nagender Kumar was first appointed on 01 Jul 2016 as Director at Tervist Pharmaceuticals Private Limited.

The current boards of Nagender Kumar's companies include Munesh Khurana (Tervist Pharmaceuticals Private Limited), Savita Attri (Tervist Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available